ANALYSIS OF THE EFFECT OF GALANTAMINE IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE (AD)

被引：0
作者：
Moruzzi, E. [1 ]
机构：
[1] Voila Hosp, Campina, Romania
来源：
EUROPEAN PSYCHIATRY | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
P-455
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Solanezumab for the treatment of mild-to-moderate Alzheimer's disease
    Imbimbo, Bruno P.
    Ottonello, Simone
    Frisardi, Vincenza
    Solfrizzi, Vincenzo
    Greco, Antonio
    Seripa, Davide
    Pilotto, Alberto
    Panza, Francesco
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (02) : 135 - 149
  • [32] Memantine in the treatment of mild-to-moderate Alzheimer's disease
    Cosman, Kelly M.
    Boyle, Llsa L.
    Porsteinsson, Anton P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) : 203 - 214
  • [33] Intravenous immunoglobulin for treatment of mild to moderate Alzheimer's disease
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (06) : 461 - 461
  • [34] The Effects of Galantamine Treatment on Attention and Its Relationship with Cognition and Activities of Daily Living in Patients with Mild to Moderate Alzheimer's Disease
    Lee, Jae-Hong
    Hong, Yun Jeong
    Bae, Hee-Joon
    Kim, Beom Joon
    Na, Duk-Lyul
    Han, Seol-Heui
    Park, Jong-Moo
    Jeong, Jee-Hyang
    Cha, Kyung-Ryeol
    JOURNAL OF CLINICAL NEUROLOGY, 2015, 11 (01): : 66 - 72
  • [35] Effects of galantamine in mild to moderate Alzheimer's disease: Results from a naturalistic, observational survey (ALLCARE)
    Cnockaert, X.
    Tessier, C.
    Foucher, A.
    Hammond, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 189 - 189
  • [36] Gastrointestinal tolerability of once-daily galantamine in subjects with mild-to-moderate Alzheimer's disease
    Dunbar, F
    Zhu, Y
    Brashear, R
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 312 - 312
  • [37] Galantamine provides long-term behavioral benefits in patients with mild to moderate Alzheimer's disease
    Bullock, R
    Kershaw, P
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S209 - S209
  • [38] Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
    Wilcock, GK
    Lilienfeld, S
    Gaens, E
    BRITISH MEDICAL JOURNAL, 2000, 321 (7274) : 1445 - 1449
  • [39] Galantamine in advanced moderate Alzheimer's disease: Long-term benefits and the effect of delayed initiation of treatment
    Blesa, R
    van Baelen, B
    Kavanagh, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S334 - S334
  • [40] Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer's disease in Brazil
    da Silva, Luciana R.
    Vianna, Cid M. M.
    Mosegui, Gabriela B. G.
    Peregrino, Antonio A. F.
    Marinho, Valeska
    Laks, Jerson
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2019, 41 (03) : 218 - 224
12345